Compendium of Cancer Genome Aberrations

Changes

Volunteer Assignments and Opportunities (view source)

Revision as of 09:02, 28 October 2022

123 bytes removed ,  09:02, 28 October 2022
no edit summary
Line 2,218: Line 2,218:     
==WHO Central Nervous System Tumours  (5th ed.) Content==
 
==WHO Central Nervous System Tumours  (5th ed.) Content==
−
{| class="wikitable"
+
| class="wikitable"
 
|-
 
|-
 
!'''Disease'''!!'''Page Type'''!!'''Author'''
 
!'''Disease'''!!'''Page Type'''!!'''Author'''
Line 2,227: Line 2,227:  
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
|-
+
|-|Astrocytoma, IDH-mutant||Disease||
−
| Astrocytoma, IDH-mutant||Disease||
   
|
 
|
 
|
 
|
Line 2,237: Line 2,236:  
|
 
|
 
|-
 
|-
−
| Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
+
|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
 
|
 
|
 
|
 
|
Line 2,246: Line 2,245:  
|
 
|
 
|-
 
|-
−
| Glioblastoma, IDH-wildtype||Disease||
+
|Glioblastoma, IDH-wildtype||Disease||
 
|
 
|
 
|
 
|
Line 2,255: Line 2,254:  
|
 
|
 
|-
 
|-
−
| Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
+
|Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
 
|
 
|
 
|
 
|
Line 2,264: Line 2,263:  
|
 
|
 
|-
 
|-
−
| Angiocentric glioma||Disease||
+
|Angiocentric glioma||Disease||
 
|
 
|
 
|
 
|
Line 2,273: Line 2,272:  
|
 
|
 
|-
 
|-
−
| Polymorphous low-grade neuroepithelial tumour of the young||Disease||
+
|Polymorphous low-grade neuroepithelial tumour of the young||Disease||
 
|
 
|
 
|
 
|
Line 2,282: Line 2,281:  
|
 
|
 
|-
 
|-
−
| Diffuse low-grade glioma, MAPK pathway-altered ||Disease||
+
|Diffuse low-grade glioma, MAPK pathway-altered ||Disease||
 
|
 
|
 
|
 
|
Line 2,291: Line 2,290:  
|
 
|
 
|-
 
|-
−
| Diffuse midline glioma, H3 K27-altered||Disease||
+
|Diffuse midline glioma, H3 K27-altered||Disease||
 
|
 
|
 
|
 
|
Line 2,300: Line 2,299:  
|
 
|
 
|-
 
|-
−
| Diffuse hemispheric glioma, H3 G34-mutant||Disease||
+
|Diffuse hemispheric glioma, H3 G34-mutant||Disease||
 
|
 
|
 
|
 
|
Line 2,309: Line 2,308:  
|
 
|
 
|-
 
|-
−
| Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
+
|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
 
|
 
|
 
|
 
|
Line 2,318: Line 2,317:  
|
 
|
 
|-
 
|-
−
| Infant-type hemispheric glioma||Disease||
+
|Infant-type hemispheric glioma||Disease||
 
|
 
|
 
|
 
|
Line 2,327: Line 2,326:  
|
 
|
 
|-
 
|-
−
| Pilocytic astrocytoma ||Disease||
+
|Pilocytic astrocytoma ||Disease||
 
|
 
|
 
|
 
|
Line 2,336: Line 2,335:  
|
 
|
 
|-
 
|-
−
| High-grade astrocytoma with piloid features||Disease||
+
|High-grade astrocytoma with piloid features||Disease||
 
|
 
|
 
|
 
|
Line 2,345: Line 2,344:  
|
 
|
 
|-
 
|-
−
| Pleomorphic xanthoastrocytoma||Disease||
+
|Pleomorphic xanthoastrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,354: Line 2,353:  
|
 
|
 
|-
 
|-
−
| Subependymal giant cell astrocytoma||Disease||
+
|Subependymal giant cell astrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,363: Line 2,362:  
|
 
|
 
|-
 
|-
−
| Chordoid glioma||Disease||
+
|Chordoid glioma||Disease||
 
|
 
|
 
|
 
|
Line 2,372: Line 2,371:  
|
 
|
 
|-
 
|-
−
| Astroblastoma, MN1-altered||Disease||
+
|Astroblastoma, MN1-altered||Disease||
 
|
 
|
 
|
 
|
Line 2,381: Line 2,380:  
|
 
|
 
|-
 
|-
−
| Ganglioglioma||Disease||
+
|Ganglioglioma||Disease||
 
|
 
|
 
|
 
|
Line 2,390: Line 2,389:  
|
 
|
 
|-
 
|-
−
| Gangliocytoma||Disease||
+
|Gangliocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,399: Line 2,398:  
|
 
|
 
|-
 
|-
−
| Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
+
|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,408: Line 2,407:  
|
 
|
 
|-
 
|-
−
| Dysembryoplastic neuroepithelial tumour||Disease||
+
|Dysembryoplastic neuroepithelial tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,417: Line 2,416:  
|
 
|
 
|-
 
|-
−
| Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
+
|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
 
|
 
|
 
|
 
|
Line 2,426: Line 2,425:  
|
 
|
 
|-
 
|-
−
| Papillary glioneuronal tumour||Disease||
+
|Papillary glioneuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,435: Line 2,434:  
|
 
|
 
|-
 
|-
−
| Rosette-forming glioneuronal tumour||Disease||
+
|Rosette-forming glioneuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,444: Line 2,443:  
|
 
|
 
|-
 
|-
−
| Myxoid glioneuronal tumour||Disease||
+
|Myxoid glioneuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,453: Line 2,452:  
|
 
|
 
|-
 
|-
−
| Diffuse leptomeningeal glioneuronal tumour||Disease||
+
|Diffuse leptomeningeal glioneuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,462: Line 2,461:  
|
 
|
 
|-
 
|-
−
| Multinodular and vacuolating neuronal tumour||Disease||
+
|Multinodular and vacuolating neuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,471: Line 2,470:  
|
 
|
 
|-
 
|-
−
| Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
+
|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
 
|
 
|
 
|
 
|
Line 2,480: Line 2,479:  
|
 
|
 
|-
 
|-
−
| Central neurocytoma||Disease||
+
|Central neurocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,489: Line 2,488:  
|
 
|
 
|-
 
|-
−
| Extraventricular neurocytoma||Disease||
+
|Extraventricular neurocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,498: Line 2,497:  
|
 
|
 
|-
 
|-
−
| Cerebellar liponeurocytoma||Disease||
+
|Cerebellar liponeurocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,507: Line 2,506:  
|
 
|
 
|-
 
|-
−
| Supratentorial ependymoma||Disease||
+
|Supratentorial ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,516: Line 2,515:  
|
 
|
 
|-
 
|-
−
| Supratentorial ependymoma, ZFTA fusion-positive ||Disease||
+
|Supratentorial ependymoma, ZFTA fusion-positive ||Disease||
 
|
 
|
 
|
 
|
Line 2,525: Line 2,524:  
|
 
|
 
|-
 
|-
−
| Supratentorial ependymoma, YAP1 fusion-positive||Disease||
+
|Supratentorial ependymoma, YAP1 fusion-positive||Disease||
 
|
 
|
 
|
 
|
Line 2,534: Line 2,533:  
|
 
|
 
|-
 
|-
−
| Posterior fossa ependymoma||Disease||
+
|Posterior fossa ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,543: Line 2,542:  
|
 
|
 
|-
 
|-
−
| Posterior fossa group A (PFA) ependymoma||Disease||
+
|Posterior fossa group A (PFA) ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,552: Line 2,551:  
|
 
|
 
|-
 
|-
−
| Posterior fossa group B (PFB) ependymoma||Disease||
+
|Posterior fossa group B (PFB) ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,561: Line 2,560:  
|
 
|
 
|-
 
|-
−
| Spinal ependymoma||Disease||
+
|Spinal ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,570: Line 2,569:  
|
 
|
 
|-
 
|-
−
| Spinal ependymoma, MYCN-amplified||Disease||
+
|Spinal ependymoma, MYCN-amplified||Disease||
 
|
 
|
 
|
 
|
Line 2,579: Line 2,578:  
|
 
|
 
|-
 
|-
−
| Myxopapillary ependymoma||Disease||
+
|Myxopapillary ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,588: Line 2,587:  
|
 
|
 
|-
 
|-
−
| Subependymoma||Disease||
+
|Subependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,597: Line 2,596:  
|
 
|
 
|-
 
|-
−
| Choroid plexus papilloma||Disease||
+
|Choroid plexus papilloma||Disease||
 
|
 
|
 
|
 
|
Line 2,606: Line 2,605:  
|
 
|
 
|-
 
|-
−
| Atypical choroid plexus papilloma||Disease||
+
|Atypical choroid plexus papilloma||Disease||
 
|
 
|
 
|
 
|
Line 2,615: Line 2,614:  
|
 
|
 
|-
 
|-
−
| Choroid plexus carcinoma||Disease||
+
|Choroid plexus carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 2,624: Line 2,623:  
|
 
|
 
|-
 
|-
−
| Medulloblastoma, WNT-activated||Disease||
+
|Medulloblastoma, WNT-activated||Disease||
 
|
 
|
 
|
 
|
Line 2,633: Line 2,632:  
|
 
|
 
|-
 
|-
−
| Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
+
|Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
 
|
 
|
 
|
 
|
Line 2,642: Line 2,641:  
|
 
|
 
|-
 
|-
−
| Medulloblastoma, SHH-activated and TP53-mutant||Disease||
+
|Medulloblastoma, SHH-activated and TP53-mutant||Disease||
 
|
 
|
 
|
 
|
Line 2,651: Line 2,650:  
|
 
|
 
|-
 
|-
−
| Medulloblastoma, non-WNT/non-SHH||Disease||
+
|Medulloblastoma, non-WNT/non-SHH||Disease||
 
|
 
|
 
|
 
|
Line 2,660: Line 2,659:  
|
 
|
 
|-
 
|-
−
| Medulloblastoma, histologically defined||Disease||
+
|Medulloblastoma, histologically defined||Disease||
 
|
 
|
 
|
 
|
Line 2,669: Line 2,668:  
|
 
|
 
|-
 
|-
−
| Atypical teratoid/rhabdoid tumour||Disease||
+
|Atypical teratoid/rhabdoid tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,678: Line 2,677:  
|
 
|
 
|-
 
|-
−
| Cribriform neuroepithelial tumour||Disease||
+
|Cribriform neuroepithelial tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,687: Line 2,686:  
|
 
|
 
|-
 
|-
−
| Embryonal tumour with multilayered rosettes||Disease||
+
|Embryonal tumour with multilayered rosettes||Disease||
 
|
 
|
 
|
 
|
Line 2,696: Line 2,695:  
|
 
|
 
|-
 
|-
−
| CNS neuroblastoma, FOXR2-activated||Disease||
+
|CNS neuroblastoma, FOXR2-activated||Disease||
 
|
 
|
 
|
 
|
Line 2,705: Line 2,704:  
|
 
|
 
|-
 
|-
−
| CNS tumour with BCOR internal tandem duplication||Disease||
+
|CNS tumour with BCOR internal tandem duplication||Disease||
 
|
 
|
 
|
 
|
Line 2,714: Line 2,713:  
|
 
|
 
|-
 
|-
−
| CNS embryonal tumour NEC/NOS||Disease||
+
|CNS embryonal tumour NEC/NOS||Disease||
 
|
 
|
 
|
 
|
Line 2,723: Line 2,722:  
|
 
|
 
|-
 
|-
−
| Pineocytoma||Disease||
+
|Pineocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,732: Line 2,731:  
|
 
|
 
|-
 
|-
−
| Pineal parenchymal tumour of intermediate differentiation||Disease||
+
|Pineal parenchymal tumour of intermediate differentiation||Disease||
 
|
 
|
 
|
 
|
Line 2,741: Line 2,740:  
|
 
|
 
|-
 
|-
−
| Pineoblastoma||Disease||
+
|Pineoblastoma||Disease||
 
|
 
|
 
|
 
|
Line 2,750: Line 2,749:  
|
 
|
 
|-
 
|-
−
| Papillary tumour of the pineal region||Disease||
+
|Papillary tumour of the pineal region||Disease||
 
|
 
|
 
|
 
|
Line 2,759: Line 2,758:  
|
 
|
 
|-
 
|-
−
| Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
+
|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
 
|
 
|
 
|
 
|
Line 2,768: Line 2,767:  
|
 
|
 
|-
 
|-
−
| Schwannoma||Disease||
+
|Schwannoma||Disease||
 
|
 
|
 
|
 
|
Line 2,777: Line 2,776:  
|
 
|
 
|-
 
|-
−
| Neurofibroma||Disease||
+
|Neurofibroma||Disease||
 
|
 
|
 
|
 
|
Line 2,786: Line 2,785:  
|
 
|
 
|-
 
|-
−
| Perineurioma||Disease||
+
|Perineurioma||Disease||
 
|
 
|
 
|
 
|
Line 2,795: Line 2,794:  
|
 
|
 
|-
 
|-
−
| Hybrid nerve sheath tumours||Disease||
+
|Hybrid nerve sheath tumours||Disease||
 
|
 
|
 
|
 
|
Line 2,804: Line 2,803:  
|
 
|
 
|-
 
|-
−
| Malignant melanotic nerve sheath tumour||Disease||
+
|Malignant melanotic nerve sheath tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,813: Line 2,812:  
|
 
|
 
|-
 
|-
−
| Malignant peripheral nerve sheath tumour||Disease||
+
|Malignant peripheral nerve sheath tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,822: Line 2,821:  
|
 
|
 
|-
 
|-
−
| Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
+
|Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
 
|
 
|
 
|
 
|
Line 2,831: Line 2,830:  
|
 
|
 
|-
 
|-
−
| Meningioma||Disease||
+
|Meningioma||Disease||
 
|
 
|
 
|
 
|
Line 2,840: Line 2,839:  
|
 
|
 
|-
 
|-
−
| Solitary fibrous tumour||Disease||
+
|Solitary fibrous tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,849: Line 2,848:  
|
 
|
 
|-
 
|-
−
| Haemangiomas and vascular malformations||Disease||
+
|Haemangiomas and vascular malformations||Disease||
 
|
 
|
 
|
 
|
Line 2,858: Line 2,857:  
|
 
|
 
|-
 
|-
−
| Haemangioblastoma||Disease||
+
|Haemangioblastoma||Disease||
 
|
 
|
 
|
 
|
Line 2,867: Line 2,866:  
|
 
|
 
|-
 
|-
−
| Rhabdomyosarcoma||Disease||
+
|Rhabdomyosarcoma||Disease||
 
|
 
|
 
|
 
|
Line 2,876: Line 2,875:  
|
 
|
 
|-
 
|-
−
| Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
+
|Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
 
|
 
|
 
|
 
|
Line 2,885: Line 2,884:  
|
 
|
 
|-
 
|-
−
| CIC-rearranged sarcoma||Disease||
+
|CIC-rearranged sarcoma||Disease||
 
|
 
|
 
|
 
|
Line 2,894: Line 2,893:  
|
 
|
 
|-
 
|-
−
| Primary intracranial sarcoma, DICER1-mutant||Disease||
+
|Primary intracranial sarcoma, DICER1-mutant||Disease||
 
|
 
|
 
|
 
|
Line 2,903: Line 2,902:  
|
 
|
 
|-
 
|-
−
| Ewing sarcoma||Disease||
+
|Ewing sarcoma||Disease||
 
|
 
|
 
|
 
|
Line 2,912: Line 2,911:  
|
 
|
 
|-
 
|-
−
| Mesenchymal chondrosarcoma||Disease||
+
|Mesenchymal chondrosarcoma||Disease||
 
|
 
|
 
|
 
|
Line 2,921: Line 2,920:  
|
 
|
 
|-
 
|-
−
| Chondrosarcoma||Disease||
+
|Chondrosarcoma||Disease||
 
|
 
|
 
|
 
|
Line 2,930: Line 2,929:  
|
 
|
 
|-
 
|-
−
| Chordoma||Disease||
+
|Chordoma||Disease||
 
|
 
|
 
|
 
|
Line 2,939: Line 2,938:  
|
 
|
 
|-
 
|-
−
| Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
+
|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
 
|
 
|
 
|
 
|
Line 2,948: Line 2,947:  
|
 
|
 
|-
 
|-
−
| Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
+
|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
 
|
 
|
 
|
 
|
Line 2,957: Line 2,956:  
|
 
|
 
|-
 
|-
−
| Primary diffuse large B-cell lymphoma of the CNS||Disease||
+
|Primary diffuse large B-cell lymphoma of the CNS||Disease||
 
|
 
|
 
|
 
|
Line 2,966: Line 2,965:  
|
 
|
 
|-
 
|-
−
| Immunodeficiency-associated CNS lymphomas||Disease||
+
|Immunodeficiency-associated CNS lymphomas||Disease||
 
|
 
|
 
|
 
|
Line 2,975: Line 2,974:  
|
 
|
 
|-
 
|-
−
| Lymphomatoid granulomatosis||Disease||
+
|Lymphomatoid granulomatosis||Disease||
 
|
 
|
 
|
 
|
Line 2,984: Line 2,983:  
|
 
|
 
|-
 
|-
−
| Intravascular large B-cell lymphoma||Disease||
+
|Intravascular large B-cell lymphoma||Disease||
 
|
 
|
 
|
 
|
Line 2,993: Line 2,992:  
|
 
|
 
|-
 
|-
−
| MALT lymphoma of the dura||Disease||
+
|MALT lymphoma of the dura||Disease||
 
|
 
|
 
|
 
|
Line 3,002: Line 3,001:  
|
 
|
 
|-
 
|-
−
| Other low-grade B-cell lymphomas of the CNS||Disease||
+
|Other low-grade B-cell lymphomas of the CNS||Disease||
 
|
 
|
 
|
 
|
Line 3,011: Line 3,010:  
|
 
|
 
|-
 
|-
−
| Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
+
|Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
 
|
 
|
 
|
 
|
Line 3,020: Line 3,019:  
|
 
|
 
|-
 
|-
−
| T-cell and NK/T-cell lymphomas||Disease||
+
|T-cell and NK/T-cell lymphomas||Disease||
 
|
 
|
 
|
 
|
Line 3,029: Line 3,028:  
|
 
|
 
|-
 
|-
−
| Erdheim-Chester disease||Disease||
+
|Erdheim-Chester disease||Disease||
 
|
 
|
 
|
 
|
Line 3,038: Line 3,037:  
|
 
|
 
|-
 
|-
−
| Rosai-Dorfman disease||Disease||
+
|Rosai-Dorfman disease||Disease||
 
|
 
|
 
|
 
|
Line 3,047: Line 3,046:  
|
 
|
 
|-
 
|-
−
| Juvenile xanthogranuloma||Disease||
+
|Juvenile xanthogranuloma||Disease||
 
|
 
|
 
|
 
|
Line 3,056: Line 3,055:  
|
 
|
 
|-
 
|-
−
| Langerhans cell histiocytosis||Disease||
+
|Langerhans cell histiocytosis||Disease||
 
|
 
|
 
|
 
|
Line 3,065: Line 3,064:  
|
 
|
 
|-
 
|-
−
| Histiocytic sarcoma||Disease||
+
|Histiocytic sarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,074: Line 3,073:  
|
 
|
 
|-
 
|-
−
| Germ cell tumours of the CNS||Disease||
+
|Germ cell tumours of the CNS||Disease||
 
|
 
|
 
|
 
|
Line 3,083: Line 3,082:  
|
 
|
 
|-
 
|-
−
| Adamantinomatous craniopharyngioma||Disease||
+
|Adamantinomatous craniopharyngioma||Disease||
 
|
 
|
 
|
 
|
Line 3,092: Line 3,091:  
|
 
|
 
|-
 
|-
−
| Papillary craniopharyngioma||Disease||
+
|Papillary craniopharyngioma||Disease||
 
|
 
|
 
|
 
|
Line 3,101: Line 3,100:  
|
 
|
 
|-
 
|-
−
| Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
+
|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,110: Line 3,109:  
|
 
|
 
|-
 
|-
−
| Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
+
|Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,119: Line 3,118:  
|
 
|
 
|-
 
|-
−
| Pituitary blastoma||Disease||
+
|Pituitary blastoma||Disease||
 
|
 
|
 
|
 
|
Line 3,128: Line 3,127:  
|
 
|
 
|-
 
|-
−
| Metastases to the brain and spinal cord parenchyma||Disease||
+
|Metastases to the brain and spinal cord parenchyma||Disease||
 
|
 
|
 
|
 
|
Line 3,137: Line 3,136:  
|
 
|
 
|-
 
|-
−
| Metastases to the meninges||Disease||
+
|Metastases to the meninges||Disease||
 
|
 
|
 
|
 
|
Line 3,146: Line 3,145:  
|
 
|
 
|-
 
|-
−
| Neurofibromatosis type 1||Disease||
+
|Neurofibromatosis type 1||Disease||
 
|
 
|
 
|
 
|
Line 3,155: Line 3,154:  
|
 
|
 
|-
 
|-
−
| Neurofibromatosis type 2||Disease||
+
|Neurofibromatosis type 2||Disease||
 
|
 
|
 
|
 
|
Line 3,164: Line 3,163:  
|
 
|
 
|-
 
|-
−
| Schwannomatosis||Disease||
+
|Schwannomatosis||Disease||
 
|
 
|
 
|
 
|
Line 3,173: Line 3,172:  
|
 
|
 
|-
 
|-
−
| Von Hippel-Lindau syndrome||Disease||
+
|Von Hippel-Lindau syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,182: Line 3,181:  
|
 
|
 
|-
 
|-
−
| Tuberous sclerosis||Disease||
+
|Tuberous sclerosis||Disease||
 
|
 
|
 
|
 
|
Line 3,191: Line 3,190:  
|
 
|
 
|-
 
|-
−
| Li-Fraumeni syndrome||Disease||
+
|Li-Fraumeni syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,200: Line 3,199:  
|
 
|
 
|-
 
|-
−
| Cowden syndrome||Disease||
+
|Cowden syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,209: Line 3,208:  
|
 
|
 
|-
 
|-
−
| Constitutional mismatch repair deficiency syndrome||Disease||
+
|Constitutional mismatch repair deficiency syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,218: Line 3,217:  
|
 
|
 
|-
 
|-
−
| Familial adenomatous polyposis 1||Disease||
+
|Familial adenomatous polyposis 1||Disease||
 
|
 
|
 
|
 
|
Line 3,227: Line 3,226:  
|
 
|
 
|-
 
|-
−
| Naevoid basal cell carcinoma syndrome||Disease||
+
|Naevoid basal cell carcinoma syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,236: Line 3,235:  
|
 
|
 
|-
 
|-
−
| Rhabdoid tumour predisposition syndrome||Disease||
+
|Rhabdoid tumour predisposition syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,245: Line 3,244:  
|
 
|
 
|-
 
|-
−
| Carney complex||Disease||
+
|Carney complex||Disease||
 
|
 
|
 
|
 
|
Line 3,254: Line 3,253:  
|
 
|
 
|-
 
|-
−
| DICER1 syndrome||Disease||
+
|DICER1 syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,263: Line 3,262:  
|
 
|
 
|-
 
|-
−
| Familial paraganglioma syndromes||Disease||
+
|Familial paraganglioma syndromes||Disease||
 
|
 
|
 
|
 
|
Line 3,272: Line 3,271:  
|
 
|
 
|-
 
|-
−
| Melanoma-astrocytoma syndrome||Disease||
+
|Melanoma-astrocytoma syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,281: Line 3,280:  
|
 
|
 
|-
 
|-
−
| Familial retinoblastoma||Disease||
+
|Familial retinoblastoma||Disease||
 
|
 
|
 
|
 
|
Line 3,290: Line 3,289:  
|
 
|
 
|-
 
|-
−
| BAP1 tumour predisposition syndrome||Disease||
+
|BAP1 tumour predisposition syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,299: Line 3,298:  
|
 
|
 
|-
 
|-
−
| Fanconi anaemia||Disease||
+
|Fanconi anaemia||Disease||
 
|
 
|
 
|
 
|
Line 3,308: Line 3,307:  
|
 
|
 
|-
 
|-
−
| ELP1-medulloblastoma syndrome||Disease||
+
|ELP1-medulloblastoma syndrome||Disease||
 
|
 
|
 
|
 
|
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/11707"